These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 26402772

  • 1. Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease.
    van Harten AC, Mulders J, Scheltens P, van der Flier WM, Oudejans CB.
    J Alzheimers Dis; 2015; 47(1):243-52. PubMed ID: 26402772
    [Abstract] [Full Text] [Related]

  • 2. MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
    Lusardi TA, Phillips JI, Wiedrick JT, Harrington CA, Lind B, Lapidus JA, Quinn JF, Saugstad JA.
    J Alzheimers Dis; 2017; 55(3):1223-1233. PubMed ID: 27814298
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
    Riancho J, Vázquez-Higuera JL, Pozueta A, Lage C, Kazimierczak M, Bravo M, Calero M, Gonalezález A, Rodríguez E, Lleó A, Sánchez-Juan P.
    J Alzheimers Dis; 2017; 57(2):483-491. PubMed ID: 28269782
    [Abstract] [Full Text] [Related]

  • 4. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
    Gui Y, Liu H, Zhang L, Lv W, Hu X.
    Oncotarget; 2015 Nov 10; 6(35):37043-53. PubMed ID: 26497684
    [Abstract] [Full Text] [Related]

  • 5. CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.
    Dangla-Valls A, Molinuevo JL, Altirriba J, Sánchez-Valle R, Alcolea D, Fortea J, Rami L, Balasa M, Muñoz-García C, Ezquerra M, Fernández-Santiago R, Lleó A, Lladó A, Antonell A.
    Mol Neurobiol; 2017 Nov 10; 54(9):6647-6654. PubMed ID: 27738874
    [Abstract] [Full Text] [Related]

  • 6. Cerebrospinal fluid CD4+ T lymphocyte-derived miRNA-let-7b can enhances the diagnostic performance of Alzheimer's disease biomarkers.
    Liu Y, He X, Li Y, Wang T.
    Biochem Biophys Res Commun; 2018 Jan 01; 495(1):1144-1150. PubMed ID: 29170128
    [Abstract] [Full Text] [Related]

  • 7. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease.
    Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T.
    J Alzheimers Dis; 2014 Jan 01; 39(2):253-9. PubMed ID: 24157723
    [Abstract] [Full Text] [Related]

  • 8. Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer's disease.
    Derkow K, Rössling R, Schipke C, Krüger C, Bauer J, Fähling M, Stroux A, Schott E, Ruprecht K, Peters O, Lehnardt S.
    PLoS One; 2018 Jan 01; 13(7):e0200602. PubMed ID: 30011310
    [Abstract] [Full Text] [Related]

  • 9. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study.
    Sørensen SS, Nygaard AB, Christensen T.
    Transl Neurodegener; 2016 Jan 01; 5():6. PubMed ID: 26981236
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal Fluid.
    Müller M, Jäkel L, Bruinsma IB, Claassen JA, Kuiperij HB, Verbeek MM.
    Mol Neurobiol; 2016 Jul 01; 53(5):2894-2899. PubMed ID: 25895659
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
    Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, Jahn H.
    PLoS One; 2015 Jul 01; 10(5):e0126423. PubMed ID: 25992776
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma.
    Bekris LM, Lutz F, Montine TJ, Yu CE, Tsuang D, Peskind ER, Leverenz JB.
    Biomarkers; 2013 Aug 01; 18(5):455-66. PubMed ID: 23822153
    [Abstract] [Full Text] [Related]

  • 13. Decreased Expression of hsa-miR-4274 in Cerebrospinal Fluid of Normal Pressure Hydrocephalus Mimics with Parkinsonian Syndromes.
    Jurjević I, Miyajima M, Ogino I, Akiba C, Nakajima M, Kondo A, Kikkawa M, Kanai M, Hattori N, Arai H.
    J Alzheimers Dis; 2017 Aug 01; 56(1):317-325. PubMed ID: 27911315
    [Abstract] [Full Text] [Related]

  • 14. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways.
    Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J, Brown D, Chen C, Prinjha RK, Richardson JC, Saunders AM, Roses AD, Richards CA.
    J Alzheimers Dis; 2008 May 01; 14(1):27-41. PubMed ID: 18525125
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease.
    McKeever PM, Schneider R, Taghdiri F, Weichert A, Multani N, Brown RA, Boxer AL, Karydas A, Miller B, Robertson J, Tartaglia MC.
    Mol Neurobiol; 2018 Dec 01; 55(12):8826-8841. PubMed ID: 29603092
    [Abstract] [Full Text] [Related]

  • 16. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.
    Pan Y, Liu R, Terpstra E, Wang Y, Qiao F, Wang J, Tong Y, Pan B.
    J Alzheimers Dis; 2016 Dec 01; 49(1):1-12. PubMed ID: 26484912
    [Abstract] [Full Text] [Related]

  • 17. miRNAs in cerebrospinal fluid associated with Alzheimer's disease: A systematic review and pathway analysis using a data mining and machine learning approach.
    Pereira JD, Teixeira LCR, Mamede I, Alves MT, Caramelli P, Luizon MR, Veloso AA, Gomes KB.
    J Neurochem; 2024 Jun 01; 168(6):977-994. PubMed ID: 38390627
    [Abstract] [Full Text] [Related]

  • 18. Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study.
    Müller M, Kuiperij HB, Versleijen AA, Chiasserini D, Farotti L, Baschieri F, Parnetti L, Struyfs H, De Roeck N, Luyckx J, Engelborghs S, Claassen JA, Verbeek MM.
    J Alzheimers Dis; 2016 Apr 16; 52(4):1321-33. PubMed ID: 27104900
    [Abstract] [Full Text] [Related]

  • 19. Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity--preliminary study.
    Kacperska MJ, Jastrzebski K, Tomasik B, Walenczak J, Konarska-Krol M, Glabinski A.
    J Mol Neurosci; 2015 May 16; 56(1):154-63. PubMed ID: 25487315
    [Abstract] [Full Text] [Related]

  • 20. A Customized Quantitative PCR MicroRNA Panel Provides a Technically Robust Context for Studying Neurodegenerative Disease Biomarkers and Indicates a High Correlation Between Cerebrospinal Fluid and Choroid Plexus MicroRNA Expression.
    Wang WX, Fardo DW, Jicha GA, Nelson PT.
    Mol Neurobiol; 2017 Dec 16; 54(10):8191-8202. PubMed ID: 27900678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.